Zephyrnet Logo

Tag: National Cancer Institute

5 Best AI medical scribes according to clinicians

In the ever-evolving landscape of healthcare, the integration of Artifcial Intelligence has signifcantly impacted various aspects of medical practice. One area where AI has...

Top News

Guardant Health introduces CRC screening test in South Korea

<!----> Precision oncology company Guardant Health has introduced the blood-based colorectal cancer (CRC) screening test, Shield,...

Beyond Cancer™ Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) in Combination with Checkpoint Inhibitor Therapy During the 2023 AACR-NCI-EORTC International Conference...

50,000 or 100,000 ppm UNO alone or in combination with anti-mCTLA-4 more than tripled antigen specific central memory T-cell response versus anti-mCTLA-4 alone...

Engineered Bacteria Can Detect Tumor DNA

September 20, 2023, by Elia Ben-Ari A team of US and Australian scientists has...

Nano-based cancer therapies may be less effective in younger patients, finds study

Researchers at The University of Texas MD Anderson Cancer Center have discovered that certain nano-based cancer therapies may be less effective in younger patients,...

New test shows promise for detecting hard-to-find cervical cancers

September 7, 2023—(BRONX, NY)—In findings with potentially important implications for cervical cancer screening, scientists at the National Cancer Institute (NCI)-designated Montefiore Einstein Cancer Center...

Asimily report highlights threats to connected healthcare devices

About the Author By Ryan Daws | 23rd August 2023 Ryan is a senior...

Largest U.S. study of e-cigarettes shows their value as smoking cessation

E-cigarettes do have value as a smoking cessation aid, according to a new study just released by a team of MUSC Hollings Cancer Center...

NCI’s CPTAC releases new proteogenomic dataset

What The National Institutes of Health is releasing a comprehensive dataset that standardizes genomic, proteomic, imaging,...

FDA Approves Talvey (talquetamab-tgvs), a First-in-Class Bispecific Therapy for the Treatment of Patients with Heavily Pretreated Multiple Myeloma

FDA Approves Talvey (talquetamab-tgvs), a First-in-Class Bispecific Therapy for the Treatment of Patients with Heavily Pretreated Multiple MyelomaHORSHAM, Pa., Aug. 10, 2023 – The...

Talazoparib Combo Approved for Metastatic Prostate Cancer

August 4, 2023, by Shana Spindler The Food and Drug Administration (FDA) has approved...

Alcanza and Clinical Research Fastrack Announce Recipients of Scholarship Honoring Juneteenth | Alcanza Clinical Research

BOSTON, M.A.  ̶   August 2, 2023  ̶   Alcanza Clinical Research, a mission-driven investigator site network and Clinical Research Fastrack, announce the Juneteenth scholarship recipients...

Can Marijuana Gummies Help You Quit Cigarettes?

In the US and Canada about 32 million people smoking – roughly 11%.  This is significantly down from the early 60s when it seemed...

Latest Intelligence

spot_img
spot_img

Chat with us

Hi there! How can I help you?